HUP0201953A2 - Benzolszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Benzolszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0201953A2 HUP0201953A2 HU0201953A HUP0201953A HUP0201953A2 HU P0201953 A2 HUP0201953 A2 HU P0201953A2 HU 0201953 A HU0201953 A HU 0201953A HU P0201953 A HUP0201953 A HU P0201953A HU P0201953 A2 HUP0201953 A2 HU P0201953A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- compounds
- chlorine
- fluorine
- hydrogen
- Prior art date
Links
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052731 fluorine Chemical group 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- -1 bicyclo[3.2.1]octanyl Chemical group 0.000 abstract 2
- 239000000460 chlorine Chemical group 0.000 abstract 2
- 239000011737 fluorine Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004487 4-tetrahydropyranyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- FOWDOWQYRZXQDP-UHFFFAOYSA-N adamantan-2-ol Chemical compound C1C(C2)CC3CC1C(O)C2C3 FOWDOWQYRZXQDP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004342 dicyclopropylmethyl group Chemical group [H]C1([H])C([H])([H])C1([H])C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A találmány (I) általános képletű vegyületekre, a képletben Ajelentése -C=C-, -CH=CH- vagy -CH2-CH2- csoport; n értéke 1 vagy 2; Xjelentése hidrogén-, klór- vagy fluoratom vagy metil- vagymetoxicsoport; Y jelentése hidrogén- vagy klór- vagy fluoratom; R1jelentése ciklohexilcsoport, amely metilcsoporttal egyszeresen,kétszeresen, háromszorosan vagy négyszeresen helyettesített;fenilcsoport, amely fluor- vagy klóratommal vagy metoxicsoporttalegyszeresen vagy kétszeresen helyettesített; cikloheptil-, terc-butil-, diciklopropilmetil-, biciklo[3.2.1]oktanil-, 4-tetrahidropiranil-, 4-tetrahidrotiopiranil- vagy 1- vagy 2-adamantil-vagy adamantán-2-ol-csoport; vagy R1 jelentése fenilcsoport, ebben azesetben azonban X és Y jelentése hidrogénatomtól eltérő; R2 jelentésehidrogénatom vagy 1-4 szénatomos alkilcsoport, amely adott esetbentrifluormetilcsoporttal helyettesített; R3 jelentése 5-7 szénatomoscikloalkilcsoport; és a vegyületek gyógyászatilag elfogadható savakkalalkotott addíciós sóira, szolvátjaira és hidrátjaira, valamint avegyületeket tartalmazó gyógyászati készítményekre vonatkozik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9907396A FR2794742B1 (fr) | 1999-06-11 | 1999-06-11 | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
PCT/FR2000/001575 WO2000076953A1 (fr) | 1999-06-11 | 2000-06-08 | Derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0201953A2 true HUP0201953A2 (hu) | 2002-12-28 |
HUP0201953A3 HUP0201953A3 (en) | 2006-03-28 |
HU228683B1 HU228683B1 (en) | 2013-05-28 |
Family
ID=9546664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0201953A HU228683B1 (en) | 1999-06-11 | 2000-06-08 | Benzene derivatives, preparation method and pharmaceutical compositions containing same |
Country Status (33)
Country | Link |
---|---|
US (1) | US6482986B1 (hu) |
EP (1) | EP1192122B1 (hu) |
JP (1) | JP4711579B2 (hu) |
KR (1) | KR100668581B1 (hu) |
CN (1) | CN1210250C (hu) |
AR (1) | AR033793A1 (hu) |
AT (1) | ATE252542T1 (hu) |
AU (1) | AU768420B2 (hu) |
BR (1) | BR0011738A (hu) |
CA (1) | CA2374631C (hu) |
CO (1) | CO5180554A1 (hu) |
CZ (1) | CZ299659B6 (hu) |
DE (1) | DE60006113T2 (hu) |
DK (1) | DK1192122T3 (hu) |
ES (1) | ES2208345T3 (hu) |
FR (1) | FR2794742B1 (hu) |
HK (1) | HK1042891B (hu) |
HU (1) | HU228683B1 (hu) |
IL (1) | IL146545A0 (hu) |
MX (1) | MXPA01012783A (hu) |
NO (1) | NO327778B1 (hu) |
NZ (1) | NZ515529A (hu) |
PL (1) | PL196491B1 (hu) |
PT (1) | PT1192122E (hu) |
RS (1) | RS49998B (hu) |
RU (1) | RU2248964C2 (hu) |
SI (1) | SI1192122T1 (hu) |
SK (1) | SK286390B6 (hu) |
TW (1) | TWI279398B (hu) |
UA (1) | UA71959C2 (hu) |
UY (1) | UY26199A1 (hu) |
WO (1) | WO2000076953A1 (hu) |
ZA (1) | ZA200109486B (hu) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10110750A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
GB2410947B (en) * | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
EP1634598A1 (en) * | 2004-09-07 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
EP2479814B1 (en) | 2005-03-28 | 2015-07-22 | Semiconductor Energy Laboratory Co, Ltd. | Light emitting device comprising a carbazole-anthracene derivative |
FR2887454B1 (fr) * | 2005-06-28 | 2009-06-05 | Sanofi Aventis Sa | Combinaisons antitumorales contenant des derives du taxane et des sigma ligands |
GB0514501D0 (en) * | 2005-07-14 | 2005-08-24 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
GB0516168D0 (en) * | 2005-08-05 | 2005-09-14 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
US7731377B2 (en) * | 2006-03-21 | 2010-06-08 | Semiconductor Energy Laboratory Co., Ltd. | Backlight device and display device |
WO2008026614A1 (en) * | 2006-08-30 | 2008-03-06 | Semiconductor Energy Laboratory Co., Ltd. | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device |
GR1005865B (el) * | 2007-01-17 | 2008-04-07 | Anavex Life Sciences Corp. | Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση. |
US7723722B2 (en) * | 2007-03-23 | 2010-05-25 | Semiconductor Energy Laboratory Co., Ltd. | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative |
FR2915994B1 (fr) * | 2007-05-11 | 2009-07-03 | Galderma Res & Dev | Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique. |
US20080286445A1 (en) * | 2007-05-17 | 2008-11-20 | Semiconductor Energy Laboratory Co., Ltd. | Composition, and method of fabricating light-emitting element |
GB0810857D0 (en) * | 2008-06-13 | 2008-07-23 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
CN102089282A (zh) * | 2008-07-08 | 2011-06-08 | 株式会社半导体能源研究所 | 咔唑衍生物、发光元件用材料、发光元件以及发光装置 |
US20110053866A1 (en) * | 2008-08-12 | 2011-03-03 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compositions |
GB2462611A (en) * | 2008-08-12 | 2010-02-17 | Cambridge Lab | Pharmaceutical composition comprising tetrabenazine |
GB2463451A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
GB2463452A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof |
GB2463283A (en) * | 2008-09-08 | 2010-03-10 | Cambridge Lab | 3,11b-cis-dihydrotetrabenazine for use in treating asthma |
KR101661328B1 (ko) * | 2008-09-19 | 2016-09-29 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 카르바졸 유도체 및 그 제조 방법 |
US8349898B2 (en) * | 2008-11-18 | 2013-01-08 | Wisconsin Alumni Research Foundation | Sigma-1 receptor ligands and methods of use |
GR1006794B (el) * | 2009-02-26 | 2010-06-04 | Αλεξανδρος Βαμβακιδης | Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση |
JP6492432B2 (ja) * | 2013-07-09 | 2019-04-03 | 東ソー株式会社 | アダマンチル基を有する環状アジン化合物、その製造方法、及びそれを構成成分とする有機電界発光素子 |
KR20170101128A (ko) | 2016-02-26 | 2017-09-05 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치 |
CA3031818A1 (en) | 2016-07-27 | 2018-02-01 | Case Western Reserve University | Compounds and methods of promoting myelination |
WO2019126702A1 (en) | 2017-12-22 | 2019-06-27 | Case Western Reserve University | Compounds for promoting myelination |
WO2019126759A1 (en) * | 2017-12-22 | 2019-06-27 | Convelo Therapeutics, Inc. | Compounds and methods of promoting myelination |
CA3229664A1 (en) * | 2021-08-23 | 2023-03-02 | William A. DONALDSON | Synthesis and evaluation of novel (4-hydroxyphenyl) substituted carbocycles as potent and selective estrogen receptor beta agonists |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4104383A (en) * | 1973-11-02 | 1978-08-01 | C M Industries | Derivatives of phenylpropenylamine |
FR2641276B1 (fr) | 1988-12-30 | 1991-07-12 | Sanofi Sa | Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant |
WO1991009594A1 (en) * | 1989-12-28 | 1991-07-11 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
ZA909902B (en) * | 1989-12-21 | 1991-10-30 | Himont Inc | Graft copolymers of polyolefins and a method of producing same |
FR2663328B1 (fr) | 1990-06-14 | 1994-08-05 | Sanofi Sa | Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant. |
CA2111957A1 (en) * | 1991-06-27 | 1993-01-07 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
US5449639A (en) | 1994-10-24 | 1995-09-12 | Taiwan Semiconductor Manufacturing Company Ltd. | Disposable metal anti-reflection coating process used together with metal dry/wet etch |
FR2751645B1 (fr) * | 1996-07-29 | 1998-12-24 | Sanofi Sa | Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales |
-
1999
- 1999-06-11 FR FR9907396A patent/FR2794742B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-07 AR ARP000102814A patent/AR033793A1/es active IP Right Grant
- 2000-06-08 CA CA2374631A patent/CA2374631C/en not_active Expired - Fee Related
- 2000-06-08 SK SK1806-2001A patent/SK286390B6/sk not_active IP Right Cessation
- 2000-06-08 RU RU2001131414/04A patent/RU2248964C2/ru not_active IP Right Cessation
- 2000-06-08 PL PL352742A patent/PL196491B1/pl not_active IP Right Cessation
- 2000-06-08 RS YUP-871/01A patent/RS49998B/sr unknown
- 2000-06-08 CO CO00042775A patent/CO5180554A1/es not_active Application Discontinuation
- 2000-06-08 ES ES00940462T patent/ES2208345T3/es not_active Expired - Lifetime
- 2000-06-08 BR BR0011738-2A patent/BR0011738A/pt not_active Application Discontinuation
- 2000-06-08 US US10/009,140 patent/US6482986B1/en not_active Expired - Lifetime
- 2000-06-08 AU AU55396/00A patent/AU768420B2/en not_active Ceased
- 2000-06-08 DE DE60006113T patent/DE60006113T2/de not_active Expired - Lifetime
- 2000-06-08 KR KR1020017015864A patent/KR100668581B1/ko not_active IP Right Cessation
- 2000-06-08 SI SI200030285T patent/SI1192122T1/xx unknown
- 2000-06-08 HU HU0201953A patent/HU228683B1/hu not_active IP Right Cessation
- 2000-06-08 MX MXPA01012783A patent/MXPA01012783A/es unknown
- 2000-06-08 CN CNB008088217A patent/CN1210250C/zh not_active Expired - Fee Related
- 2000-06-08 EP EP00940462A patent/EP1192122B1/fr not_active Expired - Lifetime
- 2000-06-08 DK DK00940462T patent/DK1192122T3/da active
- 2000-06-08 AT AT00940462T patent/ATE252542T1/de active
- 2000-06-08 CZ CZ20014443A patent/CZ299659B6/cs not_active IP Right Cessation
- 2000-06-08 IL IL14654500A patent/IL146545A0/xx not_active IP Right Cessation
- 2000-06-08 NZ NZ515529A patent/NZ515529A/xx not_active IP Right Cessation
- 2000-06-08 PT PT00940462T patent/PT1192122E/pt unknown
- 2000-06-08 JP JP2001503813A patent/JP4711579B2/ja not_active Expired - Fee Related
- 2000-06-08 WO PCT/FR2000/001575 patent/WO2000076953A1/fr active IP Right Grant
- 2000-06-09 UY UY26199A patent/UY26199A1/es not_active IP Right Cessation
- 2000-06-27 TW TW089111270A patent/TWI279398B/zh not_active IP Right Cessation
- 2000-08-06 UA UA2001117955A patent/UA71959C2/uk unknown
-
2001
- 2001-11-16 ZA ZA200109486A patent/ZA200109486B/en unknown
- 2001-12-10 NO NO20016038A patent/NO327778B1/no not_active IP Right Cessation
-
2002
- 2002-06-24 HK HK02104680.5A patent/HK1042891B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201953A2 (hu) | Benzolszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
AP1965A (en) | Tropane derivatives useful in therapy. | |
TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
ATE370145T1 (de) | Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten | |
TW200744587A (en) | Azaindole derivatives exhibiting PGD2 receptor antagonism | |
NO20060219L (no) | Forbindelser | |
DE69827236D1 (en) | Matrix-metalloproteinase-hemmer | |
MX9605156A (es) | Inhibidor de angiogenesis. | |
WO2003024441A1 (fr) | Nouvelle utilisation de composes tricycliques | |
HUP0401235A2 (hu) | 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
GB0327760D0 (en) | Compounds | |
DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
NZ332923A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
HUP0102931A2 (hu) | Új N-(triazolil-metil)-piperazin-származékok mint neurokininreceptor-antagonisták | |
YU18404A (sh) | Hemijska jedinjenja | |
EA200101209A1 (ru) | Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их | |
HUP0201863A2 (hu) | Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
HUP0202438A2 (hu) | Dioxo-tiazolidin-származékok és ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
HUP0202647A2 (hu) | Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0401194A2 (hu) | Új felületaktív anyagok, ezeket tartalmazó aeroszol készítmények és alkalmazásuk | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására | |
DE60004669D1 (de) | Indolocarbazolalkaloide aus einer marinen actinomycete | |
NO955071L (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
KR960010649A (ko) | 이중환상 옥사졸 및 티아졸 치환된 에테르 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |